Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $1,443,916.60 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Harrison R. Bane sold 56,315 shares of the company’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the sale, the insider now owns 107,037 shares in the company, valued at $2,744,428.68. This trade represents a 34.47 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $25.75 on Wednesday. The firm has a market capitalization of $3.27 billion, a P/E ratio of -53.65, a P/E/G ratio of 17.77 and a beta of 2.60. The firm’s 50-day moving average price is $21.88 and its 200-day moving average price is $26.90. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $35.29.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same period last year, the company posted $0.15 earnings per share. Equities research analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently modified their holdings of SGRY. Pier Capital LLC grew its position in Surgery Partners by 15.9% in the 4th quarter. Pier Capital LLC now owns 382,493 shares of the company’s stock valued at $8,097,000 after purchasing an additional 52,611 shares during the period. Vanguard Group Inc. lifted its stake in shares of Surgery Partners by 2.3% in the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock valued at $161,282,000 after buying an additional 172,271 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Surgery Partners by 22.4% during the fourth quarter. LPL Financial LLC now owns 16,749 shares of the company’s stock valued at $355,000 after buying an additional 3,062 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Surgery Partners during the fourth quarter worth about $273,000. Finally, Sei Investments Co. increased its position in shares of Surgery Partners by 13.9% during the fourth quarter. Sei Investments Co. now owns 43,666 shares of the company’s stock worth $924,000 after acquiring an additional 5,333 shares in the last quarter.

Analyst Upgrades and Downgrades

SGRY has been the topic of a number of recent analyst reports. Macquarie reaffirmed an “outperform” rating and issued a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. Royal Bank of Canada reduced their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Bank of America began coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Finally, JPMorgan Chase & Co. cut their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $36.56.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.